M ammalian muscle fibres differ in their contractile properties, which are dependent on myosin heavy chains (MyHC), the main protein involved in muscle contraction. For years, the reaction for myofibrillar ATPase (mATPase), the enzyme related to MyHC, was the routinely used method for muscle fibre classification. According to it, slow or type 1 and two fast fibre types, 2a and 2b, could be identified. Beside these three major fibre types, type 2c fibres could be distinguished as the intermediate ones between type 1 and type 2a (Soukup et al., 1979) .
It is known that different MyHC isoforms, each encoded by specific MyHC gene, determine fibre type characteristics. Up to now eight MyHC genes are well defined in rat and in human skeletal muscles: β-cardiac or β-slow (MyHC-1), α-cardiac, 2a, 2x, 2b, embryonic, perinatal and extraocular (Yoon et al., 1992; Schiaffino and Reggiani, 1996; Weiss et al., 1999a and b) . The two cardiac genes are located on chromosome 14 in rats and humans (Leinwand et al., 1983; Mahdavi et al., 1984) , whereas the remaining six MyHC genes are clustered on chromosome 10 in rat (Remmers et al., 1992) and 17 in humans (Yoon et al., 1992) .
In slow-twitch or type 1 fibres of mature skeletal muscles MyHC-slow or β-cardiac gene is expressed in rat and humans. In fast-twitch fibres of rat MyHC-2a, -2x and -2b genes are expressed, defining type 2a, 2x and 2b fibres respectively, expressing corresponding MyHC isoforms (De Nardi et al., 1993) . On the contrary, in humans most of studies imply that only MyHC-2a and -2x genes and corresponding isoforms are respectively expressed in histochemically classified type 2a and 2b fibres, henceforth the latter were labelled as 2x (Smerdu et al., 1994; Ennion et al., 1995; Smerdu and Eržen, 2001) .Though mRNA transcripts of MyHC-2b gene were revealed in certain skeletal muscles, MyHC-2b isoform has not been confirmed so far in humans (Horton et al., 2001) .
Skeletal muscles possess the ability to adapt to changed functional demands by fibre type transitions. Thus, the fibre type composition of skeletal muscles is often the interest of many scientists working on field of muscle research. The availability of monoclonal antibodies specific to different MyHC isoforms enabled the demonstration of MyHC isoforms within muscle fibres. One of the most widely used set of antibodies specific to different MyHC isoforms of rat, which enables the demonstration of all four major fibre types in this species, was prepared by Schiaffino and co-workers (1989) . These antibodies were applied in human skeletal muscles as well, but according to our experience the distinction of the two fast fibre types has not always been possible and the reported results were often not in agreement (Andersen and Schiaffino, 1997; Smerdu and Eržen, 2001; Horton et al., 2001) . However, there are other antibodies, some of them commercially available, whose specificity had been evaluated in different species by other scientists. In this study two commercially available anti-fast MyHC antibodies were tested for their ability to distinguish human fast MyHC isoforms. Additionally, 6H1 antibody, specific to MyHC-2x of various species (Lucas et al., 2000) was used, but only in human muscle sections.
MyHC isoforms can also be distinguished by different migration speed through polyacrylamide gels during electrophoresis. Using western-blot technique (immunoblotting), the separated MyHC bands can be blotted to nitrocellulose membrane and subsequently revealed with corresponding monoclonal antibodies. Since the muscle tissue is disrupted in order to prepare sample homogenates, the proteins may be denatured or unfolded and consequently the epitope of an antibody can be changed, incomplete or even lost.Therefore, the specificity of each antibody should be evaluated separately on muscle tissue sections and western-blots.
In this paper, we report about our experience with the set of seven antibodies, four of them specific to MyHC isoforms of rat (Schiaffino et al., 1989) and three of them specific to fast MyHC isoforms of various species, when applied on skeletal muscle sections and on immuno-blots of MyHC isoforms in rat and humans. Since many studies of skeletal muscles include the demonstration of MyHC isoforms using specific antibodies, we believe that our experience may be valuable to other scientists working on the muscle research.
Materials and Methods

Muscle samples
Extensor digitorum longus, soleus and diaphragm muscles of rat were analysed. The animals (inbred female Lewis rats) were obtained from the authorized laboratory of the rat-breeding unit of the Institute of Physiology of the Academy of Sciences, Prague, Czech Republic (Accreditation number 1020/491/A/00). The maintenance and handling of the experimental animals followed the EU Council Directive (86/609EEC) and the investigation was approved by the Expert Committee of the Institute of Physiology of the Academy of Sciences, Prague, Czech Republic. The rat muscle samples were obtained from six adult, 4-8 month-old animals during Nembutal (sodium pentobarbital, 40 mg/kg) anaesthesia, after which the animals were euthanized using Nembutal overdose.
Two human lower limb muscles, biceps femoris (knee flexor) and vastus lateralis (knee extensor) were analysed in this study. The samples were excised at autopsy (within 12 hours after death) from two presumably healthy male subjects (37 and 47 years old), who suffered sudden death. The National Medical Ethics Committee of the Republic of Slovenia approved the human muscle sampling.
The muscle samples were immediately frozen in liquid nitrogen and stored at -80ºC until they were processed for mATPase histochemistry and immunohistochemistry or sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting.
Antibodies
To identify MyHC isoforms in muscle fibres and in immuno-blots seven monoclonal antibodies specific to MyHC isoforms of different species were used ( Table 1) . Four of the antibodies, BA-D5, SC-71, BF-35 and BF-F3, were specific to rat MyHC isoforms (Schiaffino et al., 1989) .These antibodies (supernatants) were produced in the local laboratory from corresponding cell lines provided from Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ, Braunschweig, Germany). Two commercially available antibodies, A4.74, according to the manufacturer (Alexis Biochemicals) specific to MyHC-2a of human, mouse, rat and rabbit and F113.15F4, specific to MyHC-2a and -2b of various species, were used as well. Additionally, for the first time we tested recently obtained monoclonal antibody 6H1, specific to MyHC-2x of various species (Lucas et al., 2000) , but only on human skeletal muscle sections. The corresponding cell line was gifted by Dr. L. Leinwand (Department of MCD Biology, University of Colorado, Boulder, USA), the supernatant was produced in the local laboratory.
Immuno-and mATPase-histochemistry
For immunohistochemical demonstration of MyHC serial muscle cryosections (10 µm) were preincubated in phosphate buffered saline containing 0.5% bovine serum albumin (PBS/BSA) and rabbit serum (1:40) for 30 minutes. Subsequently, the sections applied with primary antibody and control sections with PBS/BSA were incubated in a humidified box overnight at 4ºC. The appropriate dilutions (with PBS/BSA) of antibodies were determined and are presented in Table 1 . The reactivity of monoclonal antibodies was revealed with HRP conjugated secondary antibody (P 260; Dako), diluted 1:100 in PBS/BSA with either rat (rat muscles) or rabbit (human muscles) serum (1:40) using an indirect immunoperoxidase technique (Gorza, 1990) . The control sections, incubated without primary antibody were completely unstained.
To determine fibre types, serial cryosections were processed also for mATPase reaction after alkaline preincubation at pH 9.4 and acid preincubation at pH 4.6, 4.5 and 4.3 (Padykula and Herman, 1955; Guth and Samaha, 1969) .
SDS-PAGE and immunoblotting
Myosin was extracted following the procedure described by d 'Albis et al. (1979) and MyHC isoforms were separated by SDS-PAGE (Talmadge and Roy, 1993) following the procedure described by Smerdu and co-workers (2005) . The electrophoresis was carried out at constant voltage (70 V) for 30 hrs at 4ºC.The separated MyHC isoforms were transferred to a nitrocellulose membrane (pore size 0.45 µm, Bio-Rad) for 18 hrs at 400 mA and additionally for 1 h at 1 A (4°C). The transfer buffer was prepared as described by Towbin and coworkers (1979) except that methanol was omitted. After the blotting the gels were silver-stained (Blum et al., 1987) and the stained MyHC isoform bands in the gel were used as controls to the blotted and immuno-labelled MyHC bands on the nitrocellulose membrane (for more details see Smerdu et al., 2005) . The appropriate dilutions of antibodies for immunoblotting were determined, they are presented in Table 1 .
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In situ hybridisation
In order to obtain further details about MyHC content in human fast fibre types, serial cryosections of human biceps femoris and vastus lateralis muscles were processed for in situ hybridisation with probes, specific to mRNA transcripts of β-slow, 2a, 2x and 2b MyHC genes (Smerdu et al., 1994; Weiss et al., 1999b) . The riboprobes were prepared with digoxgenin-labelled UTP according to the guidelines of the manufacturer (Roche Molecular Biochemicals). In situ hybridisation procedure was adapted from Horton et al. (2001) , with the following modifications: the sections were digested with 20 µg/mL of proteinase K for 7.5 minutes and the site of probe hybridisation was revealed with sheep anti-digoxigenin Fab-alkaline phosphatase conjugate (1:2000).
Results
The specificity of anti-MyHC monoclonal antibodies in rats
Using mATPase reaction only type 1, 2c, 2a and 2b fibres were revealed in rat, whereas type 2x could not be distinguished by this reaction (not shown).The four antibodies, prepared by Schiaffino and co-workers (1989) , reacted on muscle sections as expected, but on immuno-blots they showed some diversion. Monoclonal antibody BA-D5, specific to MyHC-1, intensively stained type 1 fibres and variably also type 2c fibres, known to co-express MyHC-1 and -2a isoform (Figure 1 a) . In blots BA-D5 rec- ed. However, type 2c fibres were stained with BA-D5 and SC-71 antibodies with variable intensity, obviously depending on the proportion of co-expressed isoforms (Figure 1 a and b) . On the contrary, in blots SC-71 stained MyHC-2a and MyHC-2x isoform bands with the same intensity regardless the dilution used (Figure 4 , panel A, third lane). BF-35, the antibody that recognizes all MyHC isoforms of rat except -2x, reacted as declared both in muscle sections and in blots, i.e. as unstained it revealed 2x fibres ( However, between the intensively stained and unstained fibres there was usually a certain population of fast fibres that exhibited a variable staining pattern with the applied antibodies, specific to fast 183 Original Paper MyHC isoforms, implying that they were hybrid fibres. For instance, some fibres that could be classified as unstained with BF-35 and thus considered as type 2x, were lightly stained with SC-71, which implies that they were hybrid 2ax fibres, expressing mostly MyHC-2x and a small proportion of MyHC2a. There were also other fibres that were moderately stained with BF-35, SC-71 and A4.74 antibodies, for which we assume they were also hybrid 2ax fibres with more equal proportions of coexpressed isoforms. Similarly moderately stained fibres with BF-35 and BF-F3 could be classified as 2xb. Rare fast fibres could co-express even all three fast isoforms (2axb). Since the discrimination of such hybrid fibres could be inaccurate using just bare eye, they are not labelled in Figure 1 .
The specificity of anti-MyHC monoclonal antibodies in humans
According to the histochemical reaction for mATPase type 1, 2c, 2a and 2x fibres were determined in human muscle samples (Figure 2 a-c) . Like in rat, BA-D5 stained type 1 fibres or fibres expressing β-slow MyHC transcripts (Figure 3 a) and type 2c fibres, however the latter ones with variable intensity (Figure 2 a, d) . In type 2c fibres β-slow and 2a MyHC transcripts were either coexpressed or one of them was exclusively expressed (not shown). In blots BA-D5 recognized MyHC-1 band (Figure 4, panel B, second lane) .The antibodies SC-71 and A4.74 stained histochemical type 2a and 2x human fibres (Figure 2 a-c) , but the latter ones less intensively (Figure 2 e, f) . Such trend of double-intensity labelling remained even when higher dilutions of both antibodies were applied (higher than 1:1000 for SC-71 and 1:200 for A4.74). The intensively labelled type 2a fibres predominantly expressed 2a MyHC transcripts (Figure 3 b, e, A4.74 not shown), whereas the moderately stained type 2x fibres expressed 2x MyHC transcripts (Figure 3 c, f, A4 .74 not shown). In the analysed samples 2b MyHC transcripts were not expressed (not shown). In blots we assume that the SC-71 and A4.74 antibodies labelled both very closely migrating MyHC-2a and -2x bands, which were more clearly distinguished on the silver-stained gels (Figure 4, 2a and 2x fibres (2ax) could be distinguished in sections processed for mATPase reaction and immunohistochemical staining with SC-71 and A4.74 antibodies. For the same reason as in rats the hybrid fibres are not labelled in Figure 2 .
BF-35 stained fibres that were classified as type 1, 2c, and 2a according to the mATPase reaction, whereas the histochemical type 2x fibres or fibres predominantly expressing 2x MyHC transcripts were either negative or almost unstained (labelled as 2x 1 in Figure 2 ) or moderately stained (labelled as 2x 2 in Figure 2 ). This antibody recognized only MyHC-1 and -2a in blots (Figure 4 , panel B, fifth lane). As expected, BF-F3, specific to MyHC-2b of rat, did not react with any of the human fibre types (Figure 2 The antibody 6H1, declared to be specific to MyHC-2x of various species, labelled those fibres that were moderately stained with SC-71 (Figure 3 e, f) and A4.74 (not shown), corresponded to histochemical type 2x fibres and predominantly expressed 2x MyHC transcripts (Figure 3c ).
Discussion
In this study we found that the reactivity of antibodies specific to distinct MyHC isoforms should be carefully evaluated not only among various species but with the two different techniques used, the immunohistochemistry and immunoblotting, as well. Whereas in rat fibre types and MyHC isoforms in immunoblots could be quite reliably distinguished with the antibodies used, a clear identification of human fast isoforms in muscle fibres and in blots was not always possible.
In rat, using the set of antibodies specific to rat MyHC only the reactivity of SC-71 and A4.74 with MyHC-2a and-2x MyHC bands in blots was partly unexpected finding of this study. SC-71 antibody should recognize the undigested rat MyHC-2a according to Schiaffino and co-workers (1989) . We assume that in blots in which the authors tested the specificity of this antibody, MyHC-2a and -2x isoforms co-migrated and were thus both labelled with this antibody. After the denaturation the epitopes of both antibodies must have become accessible in MyHC-2x isoform. Nevertheless, MyHC-2a and -2x bands of rat can be distinguished with BF-35 antibody, that stains all MyHC except -2x. Using appropriate dilutions and supposing that the staining intensity of fibres is proportional to the proportion of the expressed MyHC isoforms, even the identification of hybrid fibres (2c or 1/2a, 2ax, 2axb, 2xb) is possible with these antibodies (Soukup et al., 2002 and 2009, in press ).
The F113.15F4 was found to be useful to accomplish rat fast isoforms distinction as it labelled MyHC-2a and -2x in muscle sections and in blots. Our finding is in agreement with that of Marini and co-workers (1989) , who reported that a subpopulation of histochemically determined type IIB fibres of rat were unlabelled with this antibody, obviously they expressed MyHC-2b, whereas the labelled ones MyHC-2x as it was found later (Schiaffino et al., 1989) . Therefore, using F113.15F4 in rat, MyHC2x fibres can be additionally confirmed on the principle of positive reaction and 2b fibres as the negative ones. Furthermore, hybrid fibres co-expressing MyHC-2x isoform can be revealed, which is less reliable using BF-35.The 6H1 antibody, declared to be specific to MyHC-2x of rat as well (Lucas et al., 2000) , is another promising tool for the demonstration of MyHC-2x in rat and is in the process of testing in our laboratory.
In human skeletal muscles slow MyHC could be easily distinguished from the fast ones both in muscle sections and in blots. The BA-D5 antibody reliably recognizes slow MyHC isoform in various species (Smerdu and Eržen, 2001; Štrbenc et al., 2004; Smerdu et al., 2005; . Acevedo and Rivero, 2006) . Thus it seems that the BA-D5 epitope in MyHC-1 isoform is highly conserved among species, as corresponding β-slow MyHC gene is originating from the common ancestor gene (Weiss et al., 1999a and b) .
On the contrary, the identification of human fast fibre types, especially the hybrid ones, and fast MyHC bands in blots was less clear. Unfortunately, both antibodies specific to MyHC-2a in rat, i.e. SC-71 and A4.74, labelled human type 2a and 2x fibres as determined according to the mATPase reaction, the latter one less intensively. Though MyHC-2a and 2x migrated very closely in gels, we assume that both antibodies labelled both fast isoforms in blots. The trend of such double-intensity labelling of fast fibres persisted even if higher dilutions of the antibodies were used.
The same staining pattern in human skeletal muscles as found by us has been reported by others as well (Stål et al., 1994; Andersen and Schiaffino, 1997; Monemi et al., 1999; Serrano et al., 2001) . The reactivity of SC-71 with both human fast isoforms in blots as found in the present study has been also reported by Bamman and co-workers (1998) , but in another study only MyHC-2a band was labelled (Serrano et al., 2001 ). On the contrary, it has been reported that SC-71, originating from American Type Culture Collections (ATCC), specifically labelled only human type 2a fibres and corresponding MyHC band in blots (Horton et al., 2001) . Using SC-71 produced in the original laboratory (Schiaffino et al., 1989) and later in the local laboratory from hybridomas provided from DSMZ (Braunschweig, Germany), we have never noticed so specific staining of human type 2a fibres. Furthermore, this antibody stained type 2a and 2x fibres in those mammalian species in which only these two fast fibre types exist (see Acevedo and Rivero, 2006) except of horse in which only type 2a fibres and MyHC-2a isoform band were labelled (Rivero et al., 1999; Yamano et al., 2005) . But in dog, where only type 2a and 2x fibres were present as well, SC-71 labelled type 2a fibres only if used highly diluted, in blots both fast isoforms were stained (Štrbenc et al., 2004; Smerdu et al., 2005) .
Considering the specificity of A4.74 antibody to human MyHC-2a, the manufacturer refers to Hughes and co-workers (1993) , who presented the A4.74 reactivity with MyHC-2a isoform band in blots from adult human diaphragm only and not on muscle sections. Since the MyHC-2x band (marked as IIb in the paper) was very weak in the presented SDS-PAGE separation, we assume that it could be too weak to be labelled with the antibody.Therefore we conclude that A4.74 is not specific exclusively to human MyHC-2a as declared. Even in dog both fast fibre types and corresponding MyHC isoforms in blots were recognized by A4.74 (Smerdu et al., 2005) , but in horse like SC-71 the antibody A4.74 labelled only type 2a fibres (Rivero et al., 1996) .
The BF-35 antibody has for years remained the most frequently used antibody for demonstration of MyHC-2x, though its disadvantage that it reveals MyHC-2x as unstained. Already in our previous study, analysing a large number of fibres from 14 different human skeletal muscles, we found that this antibody, which recognized MyHC-1 and -2a in human blots, is not reliable for type 2x discrimination. Even with higher dilutions used BF-35 labelled about 50% of histochemical type 2x fibres and about 60% of fibres expressing 2x MyHC transcripts as revealed by in situ hybridisation technique. Since the proportion of type 2x fibres stained by BF-35 varied among different human muscles, we assumed that only pure 2x fibres remained unstained (Smerdu and Eržen, 2001 ). The same trend was noticed in this study (see Figure 2 and 3). Nevertheless, in some muscle samples histochemical type 2x fibres, which are moderately stained by SC-71 and A4.74, remain unstained by BF-35. Similar results regarding the specificity of BF-35 in human skeletal muscles were reported by others as well (Bamman et al., 1998; Serrano et al., 2001) . Moreover, the lack of BF-35 epitope seems to be common to MyHC-2x isoform of different mammals, as this antibody is able to reveal as unstained MyHC-2x isoform also in other mammalian species (see Acevedo and Rivero, 2006) , but in opossum muscles type 2x fibres were labelled by BF-35 (Sciote and Rowlerson, 1998) .
The F113.15F4 antibody is not very useful for human fast fibre types differentiation as it labelled both fast isoforms in muscle sections and in blots. The same was found in other species, in which only 2a and 2x MyHC isoforms exist, i.e. in dog and cattle (Štrbenc et al., 2004; Smerdu et al., 2005; Picard et al., 1998) . The absence of staining with BF-F3 is in agreement with the absence of type 2b fibres and corresponding 2b MyHC transcripts in human skeletal muscles (Smerdu et al., 1994; Ennion et al., 1995 , Horton et al., 2001 ; this study). The same was found in equine and canine muscles, in which type 2b fibres are not present as well (Rivero et al., 1996; Štrbenc et al., 2004; Smerdu et al., 2005) . But like in rat, BF-F3 labelled porcine type 2b fibres (Lefaucheur et al., 2002; Toniolo et al., 2004) , thus this antibody obviously recognizes MyHC-2b isoform only. Therefore, the only antibody that clearly distinguished among human type 2a and 2x fibres was just recently obtained 6H1, which was for this report tested only on human muscle sections and it stained type 2x fibres or fibres that were moderately stained with SC-71 and A4.74. The 6H1 specifically recognises human MyHC-2x in blots as well (Li et al., 2004) .
Considering all the above mentioned facts, a question imposes itself, why the specificity of SC-71, A4.74 and BF-35 antibodies varies among the species and why the distinction not only of human but of other large mammalian fast fibre types as well is so difficult with these antibodies. We see three possible explanations.
First, since it is known that that orthologue MyHC isoforms exhibit higher similarity in their amino acid sequence than paralogues, quite similar staining pattern of fast fibre types among large mammals could be expected. Thus the variable staining pattern of these antibodies among different species could be the consequence of different concentrations and sources of the antibodies, perhaps even of the inversion of their specificity and differences in immunohistochemical protocols. However, the differences in the fast MyHC isoforms proportions in fast fibres among different muscles and species should not be neglected.
Second, the double intensity labelling of fast fibres with the SC-71 and A4.74 antibodies in humans and other mammalian species could result in the fact that fast MyHC isoforms (paralogues) also exhibit quite high degree of homogeneity as they have obviously developed from a common ancestor gene (Weiss et al., 1999 a and b) . Thus fast MyHC isoforms may share the epitopes of different antibodies. In humans, the epitopes of SC-71 and A4.74 antibodies could be more abundant or perhaps more accessible in MyHC-2a isoform, as type 2a fibres were more intensively stained. It is also possible that both antibodies have differential affinity to the epitopes on the two human fast MyHC isoforms. Considering the above described facts, we could assume that the SC-71 and A4.74 antibodies differentially recognize human MyHC2a and -2x isoform. Accordingly, the hybrid 2ax fibres would exhibit a continuum of staining intensities between those of type 2a and 2x, which might be reliably evaluated with highly standardized immunohistochemical procedure and microphotometric technique (Acevedo and Rivero, 2006) . Third, if supposed that the SC-71 and A4.74 antibodies selectively recognize MyHC-2a in muscle fibres, the double intensity labelling of fast fibres in skeletal muscles of humans and of those species with similar staining pattern with the two antibodies, would mean that these muscles contain no pure type 2x fibres. The moderately stained fast fibres would be then the hybrid 2ax fibres.The fact, that all moderately stained fast fibres in this study, labelled with the 6H1 antibody as well, were mostly stained with BF-35 as seen in Figure 3 , also implies for the absence of pure 2x fibres.
Though aware that the expression of mRNA transcripts of MyHC genes does not match completely with the expressed MyHC isoforms (Andersen and Schiaffino, 1997; Smerdu and Eržen, 2001 ), but still offers additional information about MyHC status in fibres, we compared the specificity of the SC-71, A4.74, BF-35 and 6H1 antibodies with MyHC transcript expression in fibres. The predominant expression of 2x MyHC transcripts within moderately stained human fast fibres and their histochemical profile (type 2x) rather indicate for the existence of pure 2x fibres. Namely, if a permanent population of hybrid fibres is present in human skeletal muscles, then the coexpression of both corresponding MyHC transcripts would be expected in these fibres. However, it is possible that the expression of 2a MyHC transcripts in the moderately stained fast fibres is so weak that it is beyond the sensitivity of the in situ hybridisation technique. Nevertheless, a high percentage of hybrid 2ax and quite low share or even the absence of pure 2x fibres had been found in human skeletal muscles (Staron, 1991; Larsson and Moss, 1993; Harridge et al., 1996) . These fibres probably allow a highly sensitive tuning of muscle contraction properties with functional demands of organism.
Therefore, a comparative analysis of MyHC extracts of single fibres by SDS-PAGE, immunohistochemical profile of fibres, determined with antibodies that would reliably distinguish both fast isoforms, especially MyHC-2a could provide us the final answer to the above imposed questions. Considering the differences in MyHC isoforms content among different muscles, several different human skeletal muscles should be analysed.
In conclusion, according to our experience the demonstration of fast MyHC isoforms with antibodies may be quite difficult due to high homogeneity of fast paralogue isoforms and probably due to common appearance of hybrid fast fibres, particularly in human skeletal muscles in which the 6H1 antibody was found as a promising tool for the future studies. Furthermore, the reactivity of antibodies should be carefully evaluated among different species and techniques used.
